CSIMarket
 
Tabula Rasa Healthcare inc   (TRHC)
Other Ticker:  
 
    Sector  Services    Industry Professional Services
   Industry Professional Services
   Sector  Services
 
Price: $10.5000 $0.09 0.865%
Day's High: $10.5 Week Perf: 0.86 %
Day's Low: $ 10.41 30 Day Perf: 1.16 %
Volume (M): 1,307 52 Wk High: $ 10.50
Volume (M$): $ 13,720 52 Wk Avg: $7.86
Open: $10.41 52 Wk Low: $4.80



 Market Capitalization (Millions $) 267
 Shares Outstanding (Millions) 25
 Employees 1,150
 Revenues (TTM) (Millions $) 338
 Net Income (TTM) (Millions $) -95
 Cash Flow (TTM) (Millions $) 40
 Capital Exp. (TTM) (Millions $) 19

Tabula Rasa Healthcare Inc
Tabula Rasa Healthcare Inc. (TRHC) is a publicly traded healthcare technology company specializing in medication management and pharmacy services. The company was founded in 2009 by Calvin H. Knowlton, Ph.D., who is currently the Chairman and CEO.

TRHC's mission is to improve healthcare outcomes for patients and reduce healthcare costs by applying advanced technology and data analytics. The company focuses on medication safety and optimization, medication adherence, and chronic care management for individuals who have multiple chronic conditions.

TRHC's proprietary software platform, MedWisee, utilizes pharmacogenomics, clinical decision support, and medication risk mitigation to provide personalized medication management solutions for patients. The platform is used by healthcare providers, payers, and pharmacists to ensure that patients receive the right medication, at the right dose, at the right time.

TRHC also provides complete medication management services to long-term care facilities and hospice organizations through its CareKinesise division. This includes medication order review, drug utilization review, and medication dispensing and administration.

In addition to its medication management services, TRHC provides pharmacy benefit management (PBM) services through its Capstone Performance Systems division. This includes pharmacy network management, formulary design, and drug utilization management.

TRHC has grown rapidly over the past decade and currently serves over 300,000 patients nationwide. The company has received numerous awards for its innovative technology and commitment to improving healthcare outcomes, including being recognized as a Top 100 Healthcare IT Company by Becker's Hospital Review.

TRHC is headquartered in Moorestown, New Jersey, and has additional offices and operations throughout the United States. The company's vision is to be the leading provider of technology-enabled healthcare services that optimize medication use and improve patient outcomes.


   Company Address: 228 Strawbridge Drive, Suite 100 Moorestown 8057 NJ
   Company Phone Number: 648 - 2767   Stock Exchange / Ticker: NASDAQ TRHC
   TRHC is expected to report next financial results on March 09, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Tabula Rasa Healthcare Inc

Tabula Rasa Healthcare Inc Blazes Ahead with Remarkable 24.022% Revenue Increase in Second Quarter of 2023, Despite Lingering Concerns



Tabula Rasa Healthcare Inc (TRHC) has recently released its financial results for the April to June 2023 period, which show some significant improvements from the previous year. However, a closer analysis reveals several concerning factors that suggest a bearish outlook for the company. This article will explore the financial performance, inventory build-up, declining accounts receivable, and negative market trends surrounding TRHC, indicating potential long-term challenges for the company.
1. Declining Loss per Share and Improving EPS:
TRHC's financial report for the April to June 2023 period showcases a reduction in the loss per share to $-0.38, compared to $-2.07 in the same period last year. Additionally, the EPS improved from $-0.63 per share in the prior reporting season. Although these improvements may seem positive on the surface, they could be misleading due to other concerning financial indicators.

Tabula Rasa Healthcare Inc

Tabula Rasa Healthcare Inc Shows Promising Progress with Reduced Losses in Q1 2023 Earnings Season

Tabula Rasa Healthcare Inc, a provider of healthcare software solutions, has recently reported a significant reduction in loss per share for the January to March 31 2023 time-frame. Despite this positive development, there are several reasons why investors should remain cautious about investing in Tabula Rasa Healthcare Inc.
One significant reason for concern is that the company is still reporting losses, albeit at a reduced rate. The net deficit for the January to March 31 2023 time-frame was $-15.898 million, which is still a considerable amount. Additionally, the company's revenue has only increased by 31.541%, which, while an improvement, is not a significant enough increase to attract new investors.






 

Tabula Rasa Healthcare Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com